| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-14 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-10 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-09 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-08 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |